Skip to main content
Premium Trial:

Request an Annual Quote

HTG Molecular Diagnostics Files for $20M Stock Offering

NEW YORK – HTG Molecular Diagnostics said in a regulatory document on Thursday that it may offer up to $20 million in shares of its common stock from time to time.

It also signed a sales agreement with Cantor Fitzgerald for the possible sale of the shares, the Tucson, Arizona-based molecular profiling firm said in a document filed with the US Securities and Exchange Commission. 

In September the company publicly offered about 24 million shares of its stock and reached a securities purchase agreement with certain institutional investors that raised $20 million in total.

Earlier this week, HTG said that its third quarter revenues rose 15 percent year over year, and it ended the quarter with $34.8 million in cash and cash equivalents, and $3.0 million in short-term investments.

In October, it was warned by Nasdaq that it was not in compliance with a listing requirement calling for minimum closing bid price of $1 per share. 

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.